Namyangju City strengthens quarantine against’Severe Fever Thrombocytopenia Syndrome’

-[아시아타임즈=정진영 기자]Namyangju City announced on the 13th that it will strengthen publicity and quarantine activities to prevent tsutsugamushi syndrome and severe febrile thrombocytopenia syndrome (SFTS). Severe febrile thrombocytopenia syndrome is an infectious disease that is mediated by the small sophie true tick.

The city is promoting the citizen’s prevention rules and actions in 16 eups, myeons, dongs, agricultural technology centers, and village halls, etc., by the next month when the tick larvae activity is active. Joint public-private quarantine is implemented. Last month, we asked for active cooperation for early diagnosis and treatment through a meeting with the hospital director and the medical association.

It is known that severe febrile thrombocytopenia syndrome occurs a lot in middle-aged and elderly people with weakened immunity. After an incubation period of 1 to 2 weeks, fever and digestive symptoms, along with reduction of white blood cells and platelets, may occur. As of the end of September, there were 192 patients nationwide (34 patients in Gyeonggi-do) nationwide.

In the case of outdoor activities such as farm work or mountain climbing because no cure or vaccine has been developed, skin exposure should be minimized with a hat, long sleeves, and long pants to prevent tick bites. Getting rid of the ticks that are present is the best way to prevent them.

In particular, among those infected with severe febrile thrombocytopenia, the proportion of agricultural workers over their 50s is known to be high, so caution is needed in the elderly in rural areas.

If you have high fever (38 to 40 degrees Celsius) or digestive symptoms (nausea, vomiting, diarrhea, etc.) within 2 weeks after outdoor activities, you should immediately visit a medical institution for medical treatment.

The city operates a patient monitoring system through medical institutions to prevent tick-borne infectious diseases such as severe febrile thrombocytopenia syndrome.

–
– .